Opening Asia for Russia

India invited foreign experts to work on a vaccine

17.12.2020 105 просмотров

India has trained 100 experts from different countries to conduct vaccine trials.


India has trained more than 100 medical staff from other countries to conduct human trials of vaccines against coronavirus infection. According to the NDTV channel on Thursday, this program is aimed at training specialists from "friendly states" to conduct clinical trials of Indian-made drugs, which in the future will go to these countries.


According to this information, the program is being implemented at the initiative of government department of biotechnology and ministry of foreign affairs. “More than 100 participants from Afghanistan, Bhutan, Maldives, Mauritius, Nepal, Sri Lanka took part in this training program,” Alka Sharma, adviser to the Department of Biotechnology, quotes the channel as saying.


Sharma added that the next round of the training program is already being planned, which will include more participants.


In September, Indian Prime Minister Narendra Modi said, speaking at the 75th session of the UN General Assembly, that India, which has a developed pharmaceutical industry, is ready to help the world community in the production of vaccines against coronavirus. He assured that India's vaccine production will be used "to help all of humanity in the fight against this crisis."


Currently, according to the information of the Ministry of Health of India, several vaccines are undergoing various stages of clinical trials in the country at once, which in the future will be produced at Indian pharmaceutical enterprises. Among them are vaccines from Indian companies Bharat Biotech (Bharat Biotech) and Zydus Cadila (Zidus Cadila). In addition, a drug developed by the University of Oxford and the British-Swedish company AstraZeneca is being tested in the country. The Russian Direct Investment Fund (RDIF) and the pharmaceutical company Dr. Reddy's Laboratories (Dr. Reddis Laboratories) is conducting the second and third phases of clinical trials in the country of the Russian Sputnik V vaccine.

Новости партнёров